Description
Vorsetuzumab (Anti-Human CD70 Recombinant Antibody) is a human anti-CD70 antibody. Vorsetuzumab enhances macrophage-related phagocytosis of renal carcinoma cells, shows inhibitory efficacy against Burkitt’s lymphoma.
Cat.No
A607
Name
Vorsetuzumab
Chemical Properties
CAS
1165740-62-4
Synonyms
Vorsetuzumab;Research Grade Vorsetuzumab(DHE01902);Research Grade Vorsetuzumab(DHE01902);Research Grade Vorsetuzumab(DHE01902);Research Grade Vorsetuzumab(DHE01902);Research Grade Vorsetuzumab(DHE01902);Vorsetuzumab (anti-CD70);Vorsetuzumab (anti-CD70);Vorsetuzumab (anti-CD70);Vorsetuzumab (anti-CD70);Vorsetuzumab (anti-CD70);SGN-70;SGN-70;SGN-70;SGN-70;SGN-70
pH value
Corresponds to reference standard: PASS
Non-reduced CE-SDS
>95%
SEC-HPLC
>95%
Isoelectric Point
Corresponds to reference standard
Bacterial Endotoxins Test
Residual Proteins of Host Cell
Exogenous Residual DNA
Residual protein A
Biological Activity
Osmolality
Corresponds to reference standard: PASS
Peptide mapping
Corresponds to reference standard: PASS
N-terminal sequence
Corresponds to reference standard: PASS
References
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131Fax: +86-21-61642470Email:
Website:
